在恶性瘤中GPR137的研究进展:一篇评论

Yangyang Li1, ZhongQuan Yi2, Xia Li3

  • 1Department of Cardiothoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, 224000, People's Republic of China.

PubMed
概括

G蛋白结合受体 (GPCRs) 在癌症中至关重要. 孤儿GPCRGPR137促进瘤生长和转移,使其成为各种癌症的潜在治疗标.